Smoking is the greatest single cause of preventable illness and premature death in the UK. To coincide with No Smoking Day we highlight key systematic reviews available on DARE that examine the effectiveness of interventions designed to help smokers quit.
NICE recommends that all forms of NRT (and prescription only medicines) should be used only as part of a programme that includes advice from a healthcare professional or other types of support (NICE 2008).
A Cochrane Review has evaluated all of the available forms of NRT including gum, patches, nasal spray, inhalators and lozenges (Stead 2008). This well conducted review identified 132 studies involving more than 40,000 participants. It found that NRT is highly effective and can help smokers increase their chances of successfully quitting by around 60%. The provision of additional counselling although beneficial in facilitating the likelihood of a smoker quitting, is not essential to the success of NRT.
NICE state that NRT can be offered to young smokers aged 12-17 years and to pregnant or breastfeeding women who smoke (NICE 2008).
As well as NRT, NICE state that health professionals can offer, where appropriate, varenicline (Champix) or bupropion (Zyban) as possible treatments to help smokers who have said they want to stop smoking (NICE 2008).
A recent Cochrane review (Cahill 2012) evaluating the effects of varenicline identified 15 studies involving more than 12,000 participants. The well conducted review found that for studies evaluating varenicline prescribed at a standard dose doubled the chances of smokers quitting. Another well conducted review from the Cochrane Tobacco Addiction Group (Hughes 2007) included 49 studies evaluating the effects of bupropion. The review found that bupropion increased smokers’ chances of successfully quitting by around 70%.
NICE state that neither varenicline or bupropion should be offered to young people under 18 nor to pregnant or breastfeeding women (NICE 2008).
NICE suggests that providers of NHS Stop Smoking Services should offer tailored advice, counselling and support, particularly to smokers from minority ethnic and disadvantaged groups (NICE 2008).
There is good evidence that proactive telephone counselling (i.e. not initiated by calls to helplines and quitlines) can help helps smokers interested in quitting (Stead 2006; Tzelepis 2011). There is some evidence that three or more calls increase the chances of quitting compared to a minimal intervention such as providing standard self-help materials, brief advice, or compared to pharmacotherapy alone (Stead 2006).
Brief advice from doctors can help smokers to quit (Stead 2008). This well conducted Cochrane review suggests that even when doctors provide brief advice about stopping smoking, this increases the likelihood that someone who smokes will successfully quit.
The CRD Databases provide access to other critically appraised systematic reviews and economic evaluations relevant to smoking cessation. To search for these click here.
Page last updated: 19 December, 2013